论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
利用机器学习和生物信息学识别和诊断动脉粥样硬化中的溶细胞死亡基因
Authors Zhang G, Ma R, Jin H, Zhang Q, Li W, Ding Y
Received 19 February 2025
Accepted for publication 11 July 2025
Published 23 July 2025 Volume 2025:18 Pages 9767—9793
DOI https://doi.org/10.2147/JIR.S520039
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Ning Quan
Guolin Zhang,1,* Ruicong Ma,2,* Hongjin Jin,1,* Qian Zhang,2 Wenhui Li,2 Yanchun Ding1
1Department of Cardiology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, People’s Republic of China; 2The Second Hospital of Dalian Medical University, Dalian, Liaoning, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Yanchun Ding, Email yanchunding@dmu.edu.cn
Background: Lytic cell death (LCD) is gaining research attention in chronic inflammatory diseases such as atherosclerosis (AS). Our study investigates the role and mechanism of LCD in AS using machine learning and bioinformatics.
Methods: We sourced gene expression data and single-cell sequencing from the GEO database. Differential analysis identified differentially expressed genes (DEGs), which were then intersected with LCD-related genes to determine LCD-associated DEGs (LCDEGs). Machine learning was used to screen characteristic LCDEGs, and an artificial neural network (ANN) model was developed. The diagnostic accuracy of the model was assessed using ROC curves.
Results: The results demonstrated that the ANN model possesses a robust diagnostic ability in distinguishing between normal and AS cases, as well as identifying early and advanced stages. Unique AS subtypes were identified using a consensus clustering method. Two subtypes, C1 (non-immune subtype) and C2 (immune subtype), were delineated based on immune landscape analysis and gene set variation analysis functional enrichment. The chi-square test revealed that C1 was linked to early-stage (low-risk) atherosclerotic plaques, whereas C2 was associated with advanced-stage (high-risk) atherosclerotic plaques. At the single-cell level, LCDEG activity was calculated using AUCell and AddModuleScore. LCDEGs exhibited increased activity levels in macrophages within the initially classified cell subtypes. Moreover, they displayed higher activity in the “inflammation” subtype of specific macrophage subtype analysis.
Conclusion: This study highlights the clinical potential of LCD in AS and suggests it involves a macrophage-mediated mechanism. We also experimentally identified and validated cytochrome B-245β chain (CYBB) as a potential biomarker for AS.
Keywords: atherosclerosis, lytic cell death, lytic cell death-related genes, machine learning, bioinformatics, cytochrome B-245β chain, CYBB